Impact of biologic class and treatment line on psoriatic arthritis risk in psoriasis: a population-based cohort study
Background Patients with psoriasis (PsO) are at increased risk of developing psoriatic arthritis (PsA). Emerging evidence suggests that biologic therapies may differentially influence the development of PsA; however, there are no data on the relative ability of second-line biological therapy to prev...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Publishing Group
2026-05-01
|
| Serija: | RMD Open |
| Online pristup: | https://rmdopen.bmj.com/content/12/2/e006687.full |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|